Sinocare Inc. (300298.SZ) — Stock Score Summary

Sinocare Inc. (300298.SZ) has a MoatMap StockRank of 51/100 based on Quality (56/100), Value (32/100), and Momentum (48/100) factor scores. The current signal is HOLD. Sinocare is a leading Chinese manufacturer of blood glucose monitoring systems. While it has a solid domestic market share, it is a medical device company rather than a CDMO, and faces intense domestic price competition.

Sinocare Inc. is China's largest manufacturer of blood glucose monitoring systems, specializing in biosensor technology for diabetes management and point-of-care testing (POCT). The company commands a dominant share of China's retail OTC blood glucose meter market and has expanded its global footprint through strategic acquisitions like Trividia Health. Its low-cost manufacturing scale, extensive pharmacy distribution network, and expanding multi-analyte testing portfolio form a highly defensive competitive moat.

Key Financial Metrics

Price$2.21
Market Cap$1.3B
P/E (TTM)68.09
P/E (Forward)16.83
Price/Book2.62
Return on Equity1.2%
Return on Invested Capital3.0%
Debt/Equity23.40
Gross Margin49.0%
Operating Margin10.2%
Revenue Growth19.0%
Dividend Yield1.5%
Free Cash Flow$4M

Sinocare Inc. operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Sinocare Inc.’s (300298.SZ) StockRank?
MoatMap’s StockRank for Sinocare Inc. (300298.SZ) is 51/100, with a Hold signal. It is a composite of Quality (56), Value (32), and Momentum (48) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sinocare Inc. have an economic moat?
Sinocare Inc. (300298.SZ) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sinocare Inc. a buy, hold, or sell?
MoatMap’s current signal for Sinocare Inc. (300298.SZ) is Hold, based on a StockRank of 51/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sinocare Inc. in?
Sinocare Inc. (300298.SZ) operates in the Healthcare sector, specifically the Medical Devices industry (China).